CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

Clinical trial NCT07168486 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07168486
Sponsor: University of Maryland, Baltimore
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Lymphoma Diffuse Large B Cell Lymphoma (DLBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)Follicular Lymphoma Transformed Follicular Lymphoma (tFL)Mantle Cell Lymphoma Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Richter Transformation Marginal Zone Lymphoma

Start date: 2024-10-28
Primary completion: 2027-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.